Cardinal Health, Inc. (NYSE:CAH) Files An 8-K Results of Operations and Financial ConditionItem 2.02: Results of Operations and Financial Condition
On November8, 2018, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter ended September30, 2018. A copy of the news release is included as Exhibit 99.1 to this report.
Item 7.01: Regulation FD Disclosure
During a webcast scheduled to be held at 8:30 a.m. Eastern time on November8, 2018, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter ended September30, 2018 and outlook for the fiscal year ending June30, 2019. The slide presentation for the webcast will be available on the Investors page at ir.cardinalhealth.com. An audio replay of the webcast also will be available on the Investors page at ir.cardinalhealth.com.
Item 9.01: Financial Statements and Exhibits
CARDINAL HEALTH INC ExhibitEX-99.1 2 a19q1_8kx93018xexhibit991x.htm EXHIBIT 99.1 Exhibit Exhibit 99.1FOR IMMEDIATE RELEASEMedia:Ellen Barry Investors: Lisa Capodici (614) 553-3858 (614) 757-5035 [email protected] [email protected] Health Reports First Quarter Results for Fiscal Year 2019•Revenue increased 8 percent to $35.2 billion•GAAP1 operating earnings increased 211 percent to $816 million,…To view the full exhibit click
About Cardinal Health, Inc. (NYSE:CAH)
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.